All In MedTech

Device Trial Radar · NCT03207685

Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System

Characterizing Generalized Seizure Detection And Alerting In The Epilepsy Monitoring Unit With The Empatica Embrace Watch And Smartphone-Based Alert System

Last checked: Nov 19, 2026Latest source record: Feb 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Jun 30, 2017

Primary completion

Jan 15, 2019

Study completion Jan 2022

Sponsor

Lead sponsor
Empatica, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 5, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 1 month
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate safety and effectiveness of the Embrace device in identifying convulsive seizures (CS) and notifying a caregiver during patient hospitalization at an epilepsy monitoring unit (EMU).

Conditions

  • Epilepsy

Interventions

  • Additional Seizure MonitoringDevice

    Embrace could offer an additional layer of seizure monitoring

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparison of Video-EEG to Embrace SystemTime frame: 6 months

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • NYU Langone Medical Center

    New York, New York

  • Ospedale Pediatrico Bambino Gesù - Department of Neuroscience, Neurology Unit

    Roma, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.